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Abstract 
The basis for the neuroprotectant effect of D-mannitol in reducing the sensory neurological 
disturbances seen in ciguatera poisoning, is unclear. Pacific ciguatoxin-1 (P-CTX-1), at a 
concentration 10 nM, caused a statistically significant swelling of rat sensory dorsal root ganglia 
(DRG) neurons that was reversed by hyperosmolar 50 mM D-mannitol. However, using electron 
paramagnetic resonance (EPR) spectroscopy, it was found that P-CTX-1 failed to generate hydroxyl 
free radicals at concentrations of toxin that caused profound effects on neuronal excitability. 
Whole-cell patch-clamp recordings from DRG neurons revealed that both hyper- and iso-osmolar 50 
mM D-mannitol prevented the membrane depolarisation and repetitive firing of action potentials 
induced by P-CTX-1. In addition, both hyper- and iso-osmolar 50 mM D-mannitol prevented the 
hyperpolarising shift in steady-state inactivation and the rise in leakage current through tetrodotoxin 
(TTX)-sensitive Nav channels, as well as the increased rate of recovery from inactivation of 
TTX-resistant Nav channels induced by P-CTX-1. D-Mannitol also reduced, but did not prevent, the 
inhibition of peak TTX-sensitive and TTX-resistant INa amplitude by P-CTX-1. Additional 
experiments using hyper- and iso-osmolar D-sorbitol, hyperosmolar sucrose and the free radical 
scavenging agents Trolox® and L-ascorbic acid showed that these agents, unlike D-mannitol, failed to 
prevent the effects of P-CTX-1 on spike electrogenesis and Nav channel gating. These selective 
actions of D-mannitol indicate that it does not act purely as an osmotic agent to reduce swelling of 
nerves, but involves a more complex action dependent on the Nav channel subtype, possibly to alter or 
reduce toxin association. 
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1. Introduction 
Ciguatoxins are heat-stable, lipophilic cyclic polyether toxins that originate from the benthic 
dinoflagellate, Gambierdiscus spp. and accumulate in tropical and semi-pelagic reef fish via the 
marine food chain (Lewis, 2001). The human intoxication syndrome, termed ciguatera, is a form of 
ichthyosarcotoxism caused by eating fish that have bioaccumulated gambiertoxins, the precursor 
toxins that are presumably oxidised to ciguatoxins in the liver of fish (Murata et al., 1990). Ciguatera 
causes significant morbidity, affecting approximately 25,000 people worldwide each year (Lewis, 
2001). Of the many congeners of ciguatoxins that have been identified from the Indo-Pacific and 
Caribbean regions, Pacific ciguatoxin-1 (P-CTX-1) is the most abundant and the most potent congener 
(Lewis and Jones, 1997). Signs and symptoms of ciguatera poisoning fall into four main categories: 
gastrointestinal, neurological, cardiovascular and diffuse pain and weakness. The neurological 
symptoms are, however, the most distressing and include paraesthesiae, dysaesthesiae, pruritis, 
arthralgia and myalgia. The reversal of thermal sensation, where cold stimuli are felt as painful and/or 
hot, is considered a pathognomonic symptom (Schnorf et al., 2002). 
Ciguatoxins are potent activators of neuronal voltage-gated sodium (Nav) channels by binding to 
neurotoxin receptor site 5 on the Nav channel (Bidard et al., 1984). This causes membrane 
depolarisation, spontaneous action potentials and an elevation of [Na+]i, with resulting oedema 
(Bidard et al., 1984; Allsop et al., 1986; Benoit et al., 1986; Lewis and Endean, 1986; Molgó et al., 
1993; Benoit et al., 1996; Mattei et al., 1999a) . These actions result in a stimulation of transmitter 
release (Bidard et al., 1984; Molgó et al., 1990; Hamblin et al., 1995). Under voltage-clamp 
conditions, these actions appear to be the result of hyperpolarising shifts in the voltage dependence of 
activation of TTX-sensitive Nav channels (Benoit et al., 1986; Hogg et al., 1998; Strachan et al., 1999; 
Hogg et al., 2002). Furthermore, P-CTX-1 induces a TTX-sensitive leakage current in sensory 
neurons (Strachan et al., 1999) most likely from the spontaneous opening of a sub-population of Nav 
channels (Hogg et al., 1998). P-CTX-1 has also been shown to prolong action potential and 
afterhyperpolarisation duration and stimulate tonic firing in rat dorsal root ganglion (DRG) neurons as 
a result of a block of delayed-rectifier and A-type voltage-gated potassium (Kv) channels (Birinyi-
Strachan et al., 2004).  
Treatment of ciguatera with intravenous infusions of hyperosmotic D-mannitol, an acyclic sugar 
alcohol (polyol), has gained acceptance as the most effective method of abating the neurological 
symptoms (Palafox et al., 1988; Pearn et al., 1989). Over 60% of patients have their symptoms 
reversed by mannitol infusions of 1 g/kg over 30-45 min (Palafox et al., 1988; Pearn et al., 1989). 
Despite its apparent effectiveness, the mechanism for the neuroprotectant effect of D-mannitol in the 
treatment of ciguatera is still not fully understood. Most studies indicate that the reduction of cell 
swelling is the main action of D-mannitol, a well-known osmotic diuretic (Benoit et al., 1996). This 
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action is supported by the finding that D-mannitol has little effect in reducing the symptoms of 
ciguatera in mice, due to the marked absence of ciguatoxin-induced axonal oedema in the mouse 
model (Lewis and Endean, 1983; Lewis et al., 1993). In vitro studies have, however, suggested that 
D-mannitol may exert a more specific role, by interacting with the ciguatoxin molecule itself (Benoit 
et al., 1996). However, it has also been suggested that D-mannitol may exert its neuroprotectant effect 
as a scavenger of hydroxyl free radicals (•OH) generated by the ciguatoxin molecule (Pearn et al., 
1989; Benoit et al., 1996). D-Mannitol is known to act as a free radical scavenger (Magovern et al., 
1984; Desesso et al., 1994). This raises the issue as to whether this action, to prevent alterations in Nav 
channel gating, is confined only to mannitol, or is a general property shared by other sugar alcohols 
(polyols) or osmotic diuretics. 
The aims of the present study were, firstly, to determine if P-CTX-1 caused cell swelling in 
DRG sensory neurons and if D-mannitol was able to reverse this swelling. This effect has been 
previously identified with amphibian motor nerves but not mammalian sensory neurons (Benoit et al., 
1996; Mattei et al., 1997; Mattei et al., 1999b). D-Mannitol was perfused at a concentration of 50 mM 
as this approximates peak serum levels following a 1 g/kg bolus i.v. dose of mannitol used clinically 
in the treatment of ciguatera (Cloyd et al., 1986). Secondly, the study aimed to determine if P-CTX-1 
was capable of generating free radicals at physiologically relevant concentrations and establish the 
efficacy of D-mannitol to scavenge or quench these species. This was achieved using the technique of 
electron paramagnetic resonance (EPR) spectroscopy with spin trapping. The third aim was to 
determine if hyper or iso-osmolar concentrations of D-mannitol prevented or reversed the actions of 
P-CTX-1 on Nav gating and spike electrogenesis in mammalian neurons. The final aim was to 
determine if other osmotic agents such as D-sorbitol (an isomer of D-mannitol), and sucrose at the 
same concentration of 50 mM, or known free radical scavengers (Trolox® and L-ascorbic acid) 
prevented the actions of P-CTX-1 on Nav channel gating and spike electrogenesis. These final two 
aims were investigated using whole-cell patch-clamp recording from rat DRG neurons.  
 
2. Materials and Methods 
2.1. Isolation and purification of P-CTX-1. 
Pacific ciguatoxin-1 was isolated from the viscera of moray eels (Lycondontis javanicus) that 
were collected from a region of Tarawa (1.3°N, 173°E) in the Republic of Kiribati (central Pacific 
Ocean) where ciguatera is endemic. The isolation and purification techniques required to extract 
P-CTX-1 have been previously described (Lewis et al., 1991). P-CTX-1 stock (>95% pure) was 
dissolved in 50% aqueous methanol and stored in glass at –20 °C until when it was diluted with 
external solution. Control experiments were performed with 50% aqueous methanol at a maximum 
concentration of 2.2 mg/ml to assess the effects of the vehicle on neuronal excitability, Nav channel 
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gating and the generation of free radicals. 
 
2.2. DRG Isolation and Preparation. 
DRG neurons, or their afferent fibres, have been previously identified to be sites of ectopic 
impulse generation leading to the types of sensory paraesthesiae and dysaesthesiae (Wall and Devor, 
1983; Rizzo et al., 1996) reported clinically in ciguatera. All cell size, electron paramagnetic 
resonance and electrophysiological experiments were carried out using acutely dissociated newborn 
rat DRG neurons isolated as previously described (Nicholson et al., 1994). All procedures were 
approved by the joint Animal Care and Ethics Committee of the University of Technology, Sydney 
and the Royal North Shore Hospital. 
 
2.3. Cell Size Experiments. 
Glass coverslips, with adherent DRG neurons, were transferred to a perfusion chamber 
containing a glass graticule with 100 x 100 µm calibration squares on its base. Physiological external 
solution identical to that used in the voltage-clamp studies (see section 2.6) was used to perfuse the 
recording chamber. The chamber was mounted on the stage of an inverted reverse-phase polarised 
microscope (Axiovert 100, Zeiss, Germany) with continuous image projection. A CCD camera was 
connected to a PC running the AxonImaging Workbench software system (Axon Instruments, Foster 
City, CA) and continuous stream video used to monitor the neurons and freeze frame digital images 
acquired for data analysis. Around ten round DRG neurons of similar size and with no neurite 
processes were chosen on each coverslip and their precise location noted by use of the graticule. 
Digital images of each cell were taken under control conditions, following a 20-40 min perfusion in 5 
or 10 nM P-CTX-1, and following a 20-40 min perfusion in hyperosmolar 50 mM D-mannitol. 
 
2.4. Electron Paramagnetic Resonance Spectroscopy 
A Bruker™ EMX X-band EPR spectrometer, equipped with a 100 kHz modulation and a 
flattened quartz sample cell (Wilmad, NJ, USA), was used for all analyses. EPR spectra were 
recorded using the manufacturer’s acquisition software, WinEPR (Bruker-Franzen Analytic GmbH, 
Germany). Hydroxyl free radical production was investigated by, EPR spin trapping using the spin 
trap 5,5-dimethyl-1-pyrroline-N-oxide (DMPO), with the magnetic field scanned between 3440 and 
3520 G, which is within the organic radical range (Davies, 1997). The DMPO adduct of the hydroxyl 
free radical was identified by comparison of the line shape, hyperfine coupling constants and g value 
with published reference data (Buettner, 1987). The EPR signal intensity (line height) is directly 
proportional to the radical concentration, and was used to compare radical concentrations for spectra 
recorded using identical spectrometer settings (Weil et al., 1994).  
Initial experiments were designed to identify free radicals produced by P-CTX-1. The trapping 
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agent, 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) was added to the sample tube as it forms spin 
adducts (secondary radicals) with hydroxyl radicals (DMPO-OH), which can be easily measured by 
EPR spectroscopy (Buettner, 1987). Control experiments were carried out in the presence of 10 mM 
or 55 mM DMPO and the vehicle, 50% aqueous methanol.  
In order to determine if the presence of biological tissue was required for the generation of free 
radicals by P-CTX-1, DRG neurons were incubated with P-CTX-1 and the trapping agent prior to 
EPR spectroscopy. Dissociated DRG cell density was determined using a haematocytometer and 
densities of >10 neurons/20 µl of DMEM were used. Up to 960 µl of DMEM culture media, 
containing dissociated DRG neurons were pre-incubated in 5, 10 or 80 nM P-CTX-1 for up to 2 hours 
at 37°C (10% CO2, 90% humidity). The toxin and cell suspension, in addition to 55 mM DMPO was 
added to the sample cell. In separate experiments, 50 mM D-mannitol was also pre-incubated for 2 
hours with a sample containing 55 mM DMPO, 10 nM P-CTX-1 and DRG neurons in DMEM, to test 
for any inhibition of free radical production by D-mannitol. 
 
2.5. Electrophysiology. 
Electrophysiological experiments employed the patch-clamp recording technique in whole-cell 
configuration to measure current and voltage changes from single DRG neurons. Neurons were bathed 
in iso-osmotic normal external solution (see section 2.6). Patch pipettes were pulled from borosilicate 
glass capillary tubing (Corning 7052 Glass, Warner Corp.) and had resistances of 0.8-2 MΩ. 
Experiments were performed at 22 °C. 
Membrane voltage and current were recorded using an Axopatch 200A patch-clamp amplifier 
(Axon Instruments) and current and voltage pulse protocols were generated using the pClamp 
software system (Axon Instruments). Signals were filtered using an internal 5 kHz low-pass, 5-pole 
Bessel filter (–3 dB) and digitised at 15-25 kHz, depending on protocol length. Leakage and 
capacitive currents were subtracted electronically with P-P/4 procedures and series resistance 
compensation was >80% for all neurons. The voltage-clamp data recorded in this study were rejected 
if there were large leak currents upon seal formation or currents showed signs of inadequate space 
clamping. Current-clamp data were rejected if the initial resting membrane potential was more 
depolarised than –45 mV.  
 
2.6. Recording solutions. 
The effects of P-CTX-1 on action and resting potentials were investigated using current-clamp 
recordings from DRG neurons. The extracellular solution for current-clamp recordings contained (in 
mM): 120 NaCl, 3 KCl, 10 D-glucose, 1.8 CaCl2, 1.8 MgCl2, 10 
N-2-{hydroxyethyl}piperazine-N’-{2-ethanesulfonic acid} (HEPES-acid) and was adjusted to pH 7.4 
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using 1 M NaOH. The internal patch pipette solution contained (in mM): 110 KCl, 10 NaCl, 5 
HEPES-acid and was buffered to pH 7.0 with 1 M KOH. Action potentials (AP) were elicited by 1-2 
ms supramaximal currents delivered every 10 s.  
Under voltage-clamp conditions, neurons were initially bathed in normal iso-osmotic external 
solution containing (in mM): 30 NaCl, 5 CsCl, 1.8 CaCl2, 1 MgCl2, 25 D-glucose, 5 HEPES-acid, 70 
tetramethylammonium chloride (TMA-Cl), and 20 tetraethylammonium chloride (TEA-Cl) and the 
pH was adjusted to 7.4 with TEA-hydroxide. A low [Na+]o was used to minimise series resistance 
compensation and avoid saturation of the patch-clamp amplifier. Patch pipettes in voltage-clamp 
experiments were filled with an internal solution composed of (in mM): 135 CsF, 10 NaCl, and 5 
HEPES-acid. The internal solution was buffered with CsOH to pH 7.0.  
The osmolality of electrophysiological solutions was monitored with a vapour pressure 
osmometer (Gonotec Osmomat 030, Berlin, Germany). For both current-clamp and voltage-clamp 
experiments the osmolarity of the normal internal and external solutions was adjusted with sucrose to 
295-305 mOsm/l, except in iso-osmolar 50 mM D-mannitol and iso-osmolar D-sorbitol recordings, 
where no adjustment was made as the final osmolarity of these solutions ranged between to 295-305 
mOsmol/l. In experiments requiring hyperosmolar solutions, either 50 mM D-mannitol, sucrose or 
D-sorbitol was added to the control external solution, resulting in a final osmolarity of between 
345-355 mOsmol/l. Data were recorded from neurons before (control), 5-10 min after perfusion with 
osmotic agents or free radical scavengers (treatment control), and subsequently following 10 mins 
with solutions containing osmotic agents, or free radical scavengers, plus P-CTX-1. 
The predominant TTX sensitivity of the Nav channels present in each neuron was determined 
prior to current-clamp or voltage-clamp recordings using a modified steady-state Nav channel 
inactivation voltage-clamp protocol (Rash et al., 2000). This takes advantage of the separation of 
steady-state inactivation curves for TTX-sensitive and TTX-resistant Nav channels (Roy and 
Narahashi, 1992). Once the identity of the major type of sodium current (INa) was established, the 
patch-clamp amplifier was switched over to current-clamp mode and changes in the membrane 
voltage were measured. In those experiments that assessed the actions of P-CTX-1 on TTX-resistant 
Nav channels, 200 nM TTX was applied in the external solution to eliminate any residual 
TTX-sensitive INa. Only those neurons that exhibited less than 10% TTX-resistant INa, as determined 
from the modified steady-state Nav channel inactivation profile, were used to determine the actions of 
P-CTX-1 on TTX-sensitive Nav channels.  
 
2.7. Chemicals. 
All chemicals used were analytical grade and, unless otherwise stated, were obtained from 
Sigma Chemical Co., St. Louis, MO, USA. Tetrodotoxin (Calbiochem, San Diego, CA), supplied as a 
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citrate buffer, was made up as a 100 µM stock solution with sterile water and stored at –20°C for up to 
6 months. Trolox® (6-hydroxy-2,5,7,8 tetramethylchroman-2-carboxylic acid), supplied by Aldrich 
Chemicals, and L-ascorbic acid (Vitamin C) were dissolved in external solution immediately prior to 
use, stored in darkened containers and discarded immediately thereafter. DMPO was purified before 
use by treatment with activated charcoal and made up in Chelex-treated water. 
 
2.8. Data Analysis. 
Numerical data are presented as the mean ± S.E. (n, number of observations). The two-
dimensional cell area (in pixels2) was traced using the Axon Imaging software package (Axon 
Instruments™, CA, USA). Statistical analysis of cell area data was performed using a one-way 
ANOVA model for correlated samples (VassarStats™, USA). For electrophysiological experiments 
statistical analysis of pooled results were undertaken based on a one-way ANOVA model for 
weighted independent samples to determine sources of variability. Post-hoc pairwise treatment 
comparisons were performed using a Tukey’s HSD analysis from the one-way ANOVA model, at the 
P < 0.05 level. Mathematical curve fitting was accomplished using GraphPad Prism version 4.00 for 
Macintosh (GraphPad Software, San Diego CA, USA). All curve-fitting routines were performed 
using non-linear regression analysis employing a least squares method. 
The voltage-dependence of Nav channel activation was determined using a depolarising test 
pulse from -80 to +70 mV for 50 ms, in 5 mV steps. The peak INa amplitude at each voltage step was 
measured and used to construct current-voltage (INa/V) curves. 
The fitted curves for the INa/V relationships were obtained using the following equation: 
€ 
INa = gmax 1−
1
1+ exp V −V1 2( ) s[ ]
# 
$ 
% 
% 
& 
' 
( 
( 
V −Vrev( )   Equation 1 
 
where INa is the amplitude of the peak sodium current at a given test potential, V, gmax is the 
maximal Na+ conductance, V1/2 is the voltage at half-maximal activation, s is the slope factor and Vrev 
is the reversal potential. 
To determine steady-state Nav channel inactivation (h∞) a standard two-pulse protocol with a 
0.5-ms interpulse interval was applied. This consisted of a 1-s conditioning prepulse (Vprepulse), in 
which the holding potential of -80 mV was stepped to potentials ranging from -130 to 0 mV in 5 mV 
increments, followed by a 40-ms test pulse (Vtest) to -10 mV. Pulses were applied every 10 s. Data 
were either normalised to the maximum peak current in the control or maximum peak current and 
fitted using the following Boltzmann equation: 
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€ 
h∞ =
A
1+ exp[(V −V1/2 )/k]
 Equation 2 
 
where A is the fraction of control maximal peak INa (value of 1.0 under control conditions), V1/2 
is the midpoint of inactivation, k is the slope factor and V is the prepulse voltage. 
The recovery from sodium channel inactivation was examined by applying a standard two-pulse 
protocol with a variable interpulse interval (ΔT). A 300-ms conditioning prepulse (Vcond) was applied 
from a holding potential of –80 mV to –10 mV, followed by a 40-ms test pulse (Vtest), with an 
interpulse interval ranging between 0.5 ms and 1 s. The unrecovered INa fraction was used to assess 
the rate of recovery from inactivation. Rate constant values were derived by fitting the data to the 
following double exponential decay function: 
 
€ 
1 − ItestIcond = Aexp(−t/τf ) + Bexp(−t/τs)   Equation 3 
 
where A is the fraction of the total current described by a fast time constant (τf), and B is the 
fraction of the total current described by a slow time constant (τs). 
 
3. Results 
3.1. Cell Size Experiments. 
Perfusion of cells with 5 nM P-CTX-1 for 20 to 30 mins did not significantly increase DRG cell 
area (n = 66, P = 0.08). Nevertheless, perfusion with 10 nM P-CTX-1 significantly increased average 
cell area by 3.3 ± 1.6% (n = 29, P = 0.02) from 552.2 + 42.9 to 578.3 + 45.3 µm2. This increase, 
although numerically small, was statistically significant after pairwise analysis, based on a one-way 
ANOVA model for correlated samples. These experiments were performed using normal 
voltage-clamp external solution, which contained a low sodium concentration ([Na+]o = 30 mM). This 
allowed correlation of findings with subsequent patch clamp experiments using P-CTX-1 on DRG 
neurons. Additional experiments were also performed in the external solution for current-clamp 
experiments containing a physiological sodium concentration ([Na+]o =120 mM). These experiments 
found that no significant differences in the magnitude of neuronal cell swelling induced by P-CTX-1 
in either 120 mM (n = 10) or 30 mM [Na+]o. Importantly the swelling of DRG cell area was 
significantly reversed by washout in hyperosmolar 50 mM D-mannitol. Following perfusion with 10 
nM P-CTX-1, a 20-40 min washout with toxin-free hyperosmolar 50 mM D-mannitol resulted in a 
16.2 ± 4.2% (n = 66, P < 0.0001) decrease in cell area from 578.3 ± 45.3 µm2 to 500.4 ± 39.6 µm2. 
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3.2. Electron Paramagnetic Resonance (EPR) Spectroscopy. 
Control incubations containing 10 mM DMPO and the vehicle, 50% aqueous methanol, gave 
rise to EPR spectra with a characteristic signal consisting of four lines in the ratio 1:2:2:1, which has 
been assigned to the DMPO-OH adduct (Fig. 1Aa) (Buettner, 1987). Subsequent experiments were 
performed using P-CTX-1 at a high concentration of 500 nM in the presence of DMPO. The resulting 
spectrum shown in Fig. 1Ab is typical of four experiments using this concentration of P-CTX-1. As 
can been seen from Fig. 1A, no significant differences in spectral intensity of the DMPO-OH adduct 
were found between incubations in the absence and presence of 500 nM P-CTX-1.  
The production of free radicals by the P-CTX-1 molecule may require the presence of biological 
tissue. Therefore 80 nM P-CTX-1 was incubated with non-adherent acutely dissociated DRG cells 
prior to EPR analysis. Control experiments were carried out in the presence of 55 mM DMPO, the 
vehicle and DMEM culture media containing suspended DRG neurons (Fig. 1Ba). A higher spin trap 
concentration was chosen for these experiments because the spectra recorded under these conditions 
were less intense than in the absence of cells, presumably due to the presence of additional targets for 
any radicals formed. In the presence of both 80 nM P-CTX-1 and DRG neurons, the intensity of the 
DMPO-OH signal detected by EPR was significantly greater than that detected in the corresponding 
controls, indicating a increased production of DMPO-OH and hence •OH radicals (Fig. 1Bb). 
As these concentrations of P-CTX-1 are considerably higher than those that modulate Nav 
channel gating and spike electrogenesis, we performed additional EPR experiments with 5 and 10 nM 
P-CTX-1 and DRG neurons. In addition, these experiments also examined the effectiveness of 
D-mannitol to quench free radical formation. No observable change in spectral intensity were detected 
in the presence of either 5 nM (n = 2, data not shown) or 10 nM P-CTX-1 (n = 2, Fig. 1C), indicating 
minimal increased radical formation under these conditions relative to controls. The inclusion of 50 
mM hyperosmolar D-mannitol in the incubation mixtures produced only a minor reduction (<5% 
change) in the intensity of the DMPO-OH adduct signal in the presence of 10 nM P-CTX-1 and DRG 
neurons (n = 2, data not shown). 
 
3.3. D-Mannitol prevents the membrane depolarisation and repetitive action potential firing induced 
by P-CTX-1. 
To investigate the effects of D-mannitol on P-CTX-1-induced increases in membrane 
excitability, rat DRG neurons were held under current-clamp conditions and APs were generated from 
single depolarising pulses. Following perfusion with 10 nM P-CTX-1 alone the most apparent action 
was an 11.8 ± 1.6 mV (n = 13, P = 0.00017) depolarisation of the resting membrane potential (Em) 
(Fig. 2A). In the present study, this rapid membrane depolarisation was blocked by perfusing neurons 
with external solution containing either hyper- or iso-osmolar 50 mM D-mannitol, together with 10 
nM P-CTX-1 (Fig. 2B-C and Table 1). The mean P-CTX-1-induced depolarisation was significantly 
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reduced to 0.5 ± 1.3 mV (n = 5, P = 0.001) and 1.6 ± 1.2 mV (n = 8, P = 0.0006) by hyper- or 
iso-osmolar 50 mM D-mannitol, respectively. These actions were not significantly different from 
control recordings in the absence of P-CTX-1. Importantly, control experiments with hyper- or 
iso-osmolar 50 mM D-mannitol alone indicated that 50 mM D-mannitol did not alter Em (Table 1). 
Previously, Birinyi-Strachan et al. (2004) also showed that 10 nM P-CTX-1 induced stimulus-locked 
repetitive firing of AP in DRG neurons expressing TTX-sensitive Nav channels. Moreover, 1 out of 
every 4 neurons exposed to P-CTX-1 also underwent spontaneous tonic AP firing. In the present study 
both the stimulus-locked and spontaneous AP firing was inhibited by perfusion with hyper- or 
iso-osmolar 50 mM D-mannitol in the presence of 10 nM P-CTX-1.  
Hyper- or iso-osmotic D-mannitol solutions failed to inhibit the increase in AP and AHP 
duration induced by 10 nM P-CTX-1. Nevertheless, the duration of TTX-sensitive AP (measured at 
50% AP height, AP50), generated in the presence of 50 mM D-mannitol alone was also significantly 
increased from 1.3 ± 0.1 ms (n = 22) in controls to 2.3 ± 0.4 ms (n = 5, P = 0.0007) and 2.7 ± 0.4 ms 
(n = 8, P = 0.0001) in hyper- and iso-osmolar 50 mM D-mannitol, respectively (Fig. 2B-C). Therefore 
D-mannitol most likely reduces the ability of P-CTX-1 to prolong AP duration given that the 
combined effects of D-mannitol alone and P-CTX-1 alone were less than additive. Table 1 summarises 
the changes in Em and alterations in AP and AHP parameters.  
Importantly experiments also showed that perfusion with hyper- or iso-osmotic 50 mM 
D-sorbitol or hyperosmolar 50 mM sucrose in the absence of toxin did not significantly alter resting or 
AP parameters compared to controls or each other (see Table 1). This is in contrast to D-mannitol. D-
Sorbitol and sucrose both failed to prevent the marked depolarisation of Em and prolongation of AP 
duration, measured at 0 mV or 50% of maximal spike amplitude following a 10 min perfusion with 10 
nM P-CTX-1 (Table 1). These effects were not significantly different from those recorded in the 
presence of P-CTX-1 alone. Therefore unlike D-mannitol, hyper- or iso-osmolar 50 mM D-sorbitol or 
hyperosmolar 50 mM sucrose failed to inhibit changes in membrane excitability induced by 10 nM 
P-CTX-1 in DRG neurons.  
 
3.4. D-Mannitol inhibits the P-CTX-1 induced rise in the leakage current. 
A rise in Ileak commenced immediately upon perfusion with P-CTX-1 and was concentration 
dependent, with an average increase of -0.63 ± 0.12 nA (n = 69) following a 10 min perfusion in 5 nM 
P-CTX-1 (see Fig. 3). However the average Ileak induced by 5 nM P-CTX-1 was significantly reduced 
to –0.26 ± 0.08 nA (n = 13, P = 0.009) and –0.30 ± 0.1 nA (n = 9, P = 0.015) following a 10 min co-
perfusion with hyperosmolar or iso-osmolar 50 mM D-mannitol, respectively (Fig 3, Table 2). 
Importantly, Ileak recorded in the presence of hyperosmolar 50 mM D-mannitol and 5 nM P-CTX-1 was 
not significantly different from controls (n = 13, P = 0.07), however, there was still a small but 
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significant increase in mean Ileak under iso-osmolar conditions (n = 9, P = 0.02). Importantly, there 
were no significant changes in Ileak measured in either hyper or iso-osmolar 50 mM D-mannitol 
solutions alone when compared to time-matched controls (Fig. 3, Table 2).  
 
3.5. Actions of osmotic agents on the P-CTX-1 induced reduction in peak INa amplitude.  
Perfusion with hyperosmolar 50 mM D-mannitol alone for 10 min had no significant effect on 
peak TTX-sensitive INa. However hyperosmolar 50 mM D-mannitol alone did significantly reduce 
TTX-resistant INa by 16.5 ± 2.6% (n = 9, P <0.05) compared to controls. Neurons were then perfused 
with a hyperosmolar external solution containing 50 mM D-mannitol and 5 nM P-CTX-1. 
Hyperosmolar 50 mM D-mannitol failed to significantly inhibit the reduction in peak INa amplitude in 
both TTX-sensitive and TTX-resistant Nav channels, as shown in Figures 4A and C. Peak 
TTX-sensitive INa was reduced by 32.5 ± 7.7% (n = 15, P = 0.004) after a 10 min perfusion with 5 nM 
P-CTX-1 and 50 mM hyperosmotic D-mannitol (Fig. 4A). This decrease was nearly identical to that of 
TTX-resistant Nav channels, where a mean reduction of 33.1 ± 8.8% (n = 9, P = 0.005) in peak INa was 
observed in the presence of 5 nM P-CTX-1 and hyperosmolar 50 mM D-mannitol (Fig. 4C). This data 
is summarised in Table 2. Nevertheless, hyperosmolar D-mannitol most likely inhibits the ability of 
P-CTX-1 to reduce peak TTX-resistant INa amplitude given that the combined effects of D-mannitol 
alone and P-CTX-1 alone were less than additive. 
Perfusion with iso-osmolar 50 mM D-mannitol alone for 10 min had no significant effect on 
either peak TTX-sensitive or TTX-resistant INa. As under hyperosmolar conditions, iso-osmolar 50 
mM D-mannitol failed to inhibit the reduction in peak INa induced by P-CTX-1. Although the 
reductions in peak INa were interestingly smaller in iso-osmolar D-mannitol, they were still 
significantly different to control, as shown by a 23.4 ± 3.9% (n = 10, P = 0.017) and a 29.8 ± 5.2% (n 
= 4, P = 0.021) reduction in peak INa recorded from TTX-sensitive and TTX-resistant Nav channels, 
respectively (Table 2). Therefore D-mannitol reduces but does not inhibit the ability of P-CTX-1 to 
reduce peak TTX-sensitive INa amplitude. 
Control experiments also revealed that there were no significant differences between recordings 
in the presence of D-sorbitol or sucrose alone and controls for either TTX-sensitive or TTX-resistant 
INa, with one exception. Hyperosmolar 50 mM sucrose significantly decreased peak TTX-resistant INa 
current by 14.5 ± 5.0% when compared to controls (P < 0.05, n = 8, Table 2). Following perfusion 
with 5 nM P-CTX-1 in the presence of D-sorbitol or sucrose, peak INa amplitude was significantly 
reduced. P-CTX-1 caused a 23.6 ± 3.5% (P = 0.02, n = 4), 33.4 ± 4.9% (P = 0.001, n = 4) and 45 ± 
4.8% (P < 0.0001, n = 9) reduction in peak TTX-sensitive INa in the presence of hyper-, iso-osmolar 
50 mM D-sorbitol or hyperosmolar 50 mM sucrose, respectively (Table 3). In addition, P-CTX-1 
caused a 30.9 ± 9.8% (P = 0.05, n = 4), 39.7 ± 4.2% (P = 0.001, n = 4) and 33.9 ± 7.1% (P < 0.04, n = 
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6) reduction in peak TTX-resistant INa in the presence of hyper-, iso-osmolar 50 mM D-sorbitol or 
hyperosmolar 50 mM sucrose respectively (Table 3). As with hyper- and iso-osmolar D-mannitol, 
there were also no significant differences in the reduction in peak INa between recordings in 5 nM 
P-CTX-1 in the presence of osmotic agents when compared to recordings in 5 nM P-CTX-1 alone for 
both TTX-sensitive and TTX-resistant INa. This indicates that sucrose and D-sorbitol failed to prevent 
the P-CTX-1-induced inhibition of TTX-sensitive and TTX-resistant INa. 
 
3.6. Actions of osmotic agents on the P-CTX-1-induced shift in the voltage dependence of 
TTX-sensitive Nav activation. 
P-CTX-1 caused a hyperpolarising shift in the voltage-dependence of TTX-sensitive Nav 
channel activation. Figures 5A-D shows families of TTX-sensitive INa traces generated by a standard 
INa/V protocol (see Fig. 5A inset). In initial control experiments, hyperosmolar or iso-osmolar 50 mM 
D-mannitol alone had no significant effect on the voltage dependence of TTX-sensitive Nav channel 
activation compared to controls (Table 2). In the presence of 5 nM P-CTX-1, D-mannitol varied in its 
ability to inhibit the 13 mV hyperpolarising shift in the V1/2 in TTX-sensitive Nav channels. Perfusion 
with hyperosmolar 50 mM D-mannitol and 5 nM P-CTX-1 for 10 min resulted in a smaller, but still 
significant, shift of –11 ± 3 mV in the midpoint of activation for TTX-sensitive Nav channels 
compared to controls (n = 6, P = 0.03). This hyperpolarising shift is evident in the altered threshold of 
INa activation observed in the current/voltage (INa/V) curve (Fig. 5E). In addition, a post-hoc analysis 
found no significant difference in the V1/2 between recordings in hyperosmolar 50 mM D-mannitol and 
5 nM P-CTX-1 versus recordings in 5 nM P-CTX-1 alone (Table 2).  
In contrast, iso-osmolar 50 mM D-mannitol significantly inhibited the P-CTX-1-induced shift in 
the voltage-dependence of TTX-sensitive Nav channel activation (Fig. 5C-D). The mean shift in the 
voltage-midpoint of activation of only –2 ± 3 mV following a 10 min perfusion in iso-osmolar 50 mM 
D-mannitol and 5 nM P-CTX-1 was not significantly different from controls (Table 2). These results 
indicate that iso-osmolar, but not hyperosmolar, 50 mM D-mannitol significantly inhibits the 
P-CTX-1-induced shift in the voltage dependence of TTX-sensitive Nav channel activation. The 
reversal potential (Vrev) and slope factor (s) were not significantly altered in the presence of either 
hyper- or iso-osmolar D-mannitol, either alone or in the presence of 5 nM P-CTX-1.  
Perfusion with 50 mM hyperosmolar D-sorbitol or sucrose, or 50 mM iso-osmolar D-sorbitol 
alone did not cause a significant shift in V1/2 when compared to controls or each other. In the presence 
of hyper- and iso-osmolar D-sorbitol, 5 nM P-CTX-1 caused a significant 13 ± 3 mV (P < 0.05, n = 3) 
and 11 ± 3 mV (P < 0.05, n = 4) hyperpolarising shift in the V1/2 for TTX-sensitive Nav channel 
activation, respectively, not significantly different to the shift in the presence of 5 nM P-CTX-1 alone 
(Table 3). No significant changes in the slope factor (s) were noted from the D-sorbitol or sucrose I/V 
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curves. Hence D-sorbitol failed to inhibit the P-CTX-1-induced hyperpolarising shift in V1/2. However, 
hyperosmolar 50 mM sucrose significantly reduced the shift in V1/2 by 5 nM P-CTX-1 to only 5 ± 3 
mV. This was significantly different from the –13 ± 1 mV (P = 0.03, n = 7) shift in V1/2 in the presence 
of P-CTX-1 alone and not significantly different from the V1/2 recorded in the presence of 
hyperosmolar 50 mM sucrose alone (Table 3). 
 
3.7. D-Mannitol prevents the P-CTX-1-induced hyperpolarising shift in TTX-sensitive steady-state 
sodium channel inactivation (h∞).  
P-CTX-1 caused a 22 mV hyperpolarising shift in steady-state TTX-sensitive Nav channel 
inactivation Figure 6A shows typical TTX-sensitive INa traces recorded at three different prepulse 
potentials (–130, –80 and –40 mV) before, and 10 min following, perfusion with 5 nM P-CTX-1 in 
the presence of hyperosmolar 50 mM D-mannitol. The peak INa recorded during the test pulse were 
then either expressed as a fraction of maximum peak control INa amplitude (Fig. 6B and D), or 
normalised to the maximum INa amplitude (Fig. 6C and E). Firstly, Fig. 6B and D highlight the 
inability of D-mannitol to completely inhibit the P-CTX-1-induced decrease in peak INa at all prepulse 
potentials, as seen in Figure 4. At a prepulse potential of –130 mV, the peak INa amplitude was 
reduced by 28 ± 8% (n = 7) and 29 ± 5% (n = 9) in the presence of hyper- and iso-osmolar D-mannitol 
plus P-CTX-1, respectively. However, perfusion of 5 nM P-CTX-1 in the presence of 50 mM 
hyperosmolar D-mannitol significantly reduced the hyperpolarising shift in the voltage mid-point of 
inactivation (V1/2) of TTX-sensitive Nav channel h∞ to only to +1 ± 3 mV (n = 7, P = 0.0006). This was 
not significantly different from controls (Table 2). The shift in the TTX-sensitive Nav channel h∞ curve 
was also prevented by iso-osmolar D-mannitol, reduced to only –2 ± 2 (n = 9, P = 0.0003), as shown 
in Figs 6C and E. No significant changes in V1/2 were recorded in 50 mM D-mannitol alone. There 
were also no significant changes in the slope factors (s) of all h∞ curves recorded in the presence of 50 
mM D-mannitol alone. 
No significant changes in the voltage mid-point of inactivation (V1/2) were recorded in either 
hyperosmolar 50 mM D-sorbitol or 50 mM sucrose alone, when compared to controls or each other 
(Table 3). However, perfusion with hyperosmolar D-sorbitol in the presence of 5 nM P-CTX-1 
significantly shifted the h∞ curve 20 ± 4 mV in the hyperpolarising direction (P = 0.01, n = 3). A 
similar hyperpolarising shift in V1/2 of 15 ± 4 mV (P = 0.03, n = 6) also occurred after perfusion with 
hyperosmolar sucrose in the presence of 5 nM P-CTX-1. These hyperpolarising shifts in V1/2 were not 
statistically different to the –22 mV shift induced by P-CTX-1 alone. No significant changes in the 
slope factor (k) were noted in the hyperosmolar D-sorbitol or sucrose h∞ curves. These results indicate 
that both hyperosmolar D-sorbitol and sucrose failed to inhibit the P-CTX-1-induced hyperpolarising 
shift in TTX-sensitive steady-state Nav channel inactivation.  
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3.8. D-Mannitol prevents the action of P-CTX-1 on the rate of recovery from TTX-resistant Nav 
channel inactivation. 
P-CTX-1 increased the rate of recovery of inactivation in TTX-resistant INa. In the unrecovered 
fraction this was seen as a significant increase in coefficient A (with a corresponding decrease in 
coefficient B) describing the fast time constant (τf) from 0.40 ± 0.04 to 0.64 ± 0.05, and a decrease in 
τf from 9.1 ± 1.2 ms to 4.5 ± 0.9 ms. This indicates an increase in the rate of channel repriming 
kinetics (Table 2). In the present study, perfusion with hyper or iso-osmolar 50 mM D-mannitol 
prevented any significant increase in the rate of recovery of TTX-resistant Nav channel inactivation by 
5 nM P-CTX-1. Analysis of the repriming kinetics revealed no significant difference from controls in 
the time constants or coefficients describing the unrecovered fraction (Fig. 7B and D and Table 2). 
Also both hyper- and iso-osmolar solutions containing 50 mM D-mannitol in the absence of toxin had 
no effect on the rate of recovery from inactivation for TTX-resistant INa (data not shown). 
 
3.9. Ability of hyperosmolar D-mannitol to reverse the actions of P-CTX-1. 
We also examined the ability of hyperosmolar D-mannitol to reverse the effects of P-CTX-1 on 
TTX-sensitive and TTX-resistant INa. To explore this aspect of reversibility, 5 nM P-CTX-1 was 
added to the external bath solution prior to a 25 min washout with hyperosmolar D-mannitol alone 
(i.e. in toxin-free solution). Three main aspects of Nav channel gating that were significantly altered 
by P-CTX-1 were investigated. Firstly, washout in hyperosmolar 50 mM D-mannitol failed to reverse 
the P-CTX-1-induced reduction in peak INa amplitude for both TTX-sensitive (n = 7, P = 0.63) and 
TTX-resistant (n = 5, P = 0.34) Nav channels (data not shown). Secondly, hyperosmolar 50 mM 
D-mannitol failed to significantly reverse the large hyperpolarising shift in steady-state inactivation 
induced by P-CTX-1 in TTX-sensitive Nav channels, with only 1 out of 7 experiments showed any 
evidence of reversibility (data not shown). Importantly, this is in contrast to previous experiments 
where hyperosmolar concentrations of D-mannitol were shown to completely inhibit the 
hyperpolarising shift in TTX-S steady-state inactivation. In experiments on TTX-resistant Nav 
channels, washout with 50 mM hyperosmolar solutions of D-mannitol, also failed to reverse the 
P-CTX-1-induced increase in the rate of recovery from inactivation (n = 5, data not shown). 
 
3.10. Actions of free radical scavengers on P-CTX-1 modified Nav channels. 
In the present study, EPR spectroscopy identified that at 10 nM P-CTX-1 there was no 
measurable change in radical adduct signal intensity, although this may be at the limit of resolution of 
this technique. Therefore it was important to determine whether free radicals contributed to the 
modulation of Nav channel gating at a toxin concentration of 10 nM, by assessing the ability of known 
 L.C. Birinyi-Strachan et al.  16 
free radical scavengers to inhibit or reverse these actions. Trolox® 
(6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid), is a water-soluble and cell-permeable 
analogue of vitamin E. Trolox® has been shown to scavenge free radicals, particularly the hydroxyl 
radical (Giulivi and Cadenas, 1993) which has been postulated to be generated by ciguatera, with a 
rate constant, k, of 7 x 109 dm3/mol/s (Davies et al., 1988). L-Ascorbic acid (vitamin C), also has a 
proven experimental record as an anti-oxidant both in vivo and in vitro (Frei et al., 1989) reacting with 
hydroxyl radicals with a rate constant, k, of 1.1 x 1010 dm3/mol/s (Buxton et al., 1988). 
The ability of both Trolox® and L-ascorbic acid to prevent effects of P-CTX-1 on Nav gating 
were firstly assessed on INa amplitude. Cells were perfused with either 100 µM Trolox® or 100 µM L-
ascorbic acid for 10-15 minutes prior to addition of 10 nM P-CTX-1. A 10-15 minute perfusion in 
either 100 µM Trolox® or 100 µM L-ascorbic acid alone did not significantly alter peak TTX-sensitive 
INa. However, while Trolox alone did not significantly alter TTX-resistant INa, L-ascorbic acid alone 
significantly reduced peak INa by 14.1 ± 8.4% (P = 0.04, n = 6) compared to controls. This reduction 
in peak current was similar to that detected with hyperosmolar D-mannitol or hyperosmolar sucrose 
alone (see Table 3), which also decreased peak TTX-resistant INa by 18.5% and 14.5%, respectively. 
However both Trolox® and L-ascorbic acid failed to significantly reduce the large P-CTX-1-induced 
inhibition of peak TTX-sensitive and TTX-resistant INa.  
Following perfusion with 10 nM P-CTX-1 in the presence of the free radical scavengers, peak 
INa amplitude was significantly reduced. P-CTX-1 caused a 50.5 ± 6.3% (P < 0.0001, n = 5) and 58.7 
± 3.7% (P = 0.0001, n = 4) reduction in peak TTX-sensitive INa in the presence of Trolox® or L-
ascorbic acid, respectively (Table 3). In addition, 10 nM P-CTX-1 caused a 67.3 ± 7.4% (P = 0.0001, 
n = 4) and 50.6 ± 1.3% (P = 0.004, n = 5) reduction in peak TTX-resistant INa in the presence of 
Trolox® or L-ascorbic acid, respectively (Table 3). As with hyper- and iso-osmolar D-mannitol, there 
were no significant differences in the reduction in peak INa between recordings in 10 nM P-CTX-1 in 
the presence of the free radical scavengers when compared to recordings in 10 nM P-CTX-1 alone for 
both TTX-sensitive and TTX-resistant INa. This indicates that Trolox® or L-ascorbic acid failed to 
prevent the P-CTX-1-induced inhibition of TTX-sensitive and TTX-resistant Nav channels. 
 
3.11. Trolox® and L-ascorbic acid fail to inhibit the P-CTX-1-induced alterations in the voltage 
dependence of Nav channel activation. 
Perfusion with 100 µM Trolox® or L-ascorbic acid alone did not cause a significant shift in V1/2 
when compared to controls. In the presence of 100 µM Trolox® or L-ascorbic acid, 5 nM P-CTX-1 
caused a significant 10 ± 2 mV (P < 0.05, n = 5) and 11 ± 3 mV (P < 0.05, n = 4) hyperpolarising shift 
in the V1/2 for TTX-sensitive Nav channel activation, respectively, not significantly different to the –13 
± 1 mV (n = 7) shift in the presence of 5 nM P-CTX-1 alone. No significant changes in the slope 
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factor (s) were noted from the Trolox® and L-ascorbic acid I/V curves. Therefore these agents failed to 
prevent the P-CTX-1-induced shift in the voltage dependence of activation. 
 
3.12. Trolox® and L-ascorbic acid fail to inhibit the P-CTX-1-induced alterations in TTX-sensitive Nav 
channel steady-state inactivation (h∞).  
Like the osmotic agents tested previously, both Trolox® and L-ascorbic acid failed to inhibit the 
22 mV hyperpolarising shift in the TTX-sensitive steady-state Nav channel inactivation curve induced 
by 5 nM P-CTX-1. No significant changes in the voltage mid-point of inactivation (V1/2) were detected 
with either 100 µM Trolox® or 100 µM L-ascorbic acid, when compared to controls or each other 
(Table 3). However, perfusion with 100 µM Trolox® in the presence of 5 nM P-CTX-1 significantly 
shifted the h∞ curve 30 ± 6 mV in the hyperpolarising direction (P = 0.001, n = 4). A similar 
hyperpolarising shift in the V1/2 of –23 ± 5 mV (P = 0.01, n = 4) also occurred after TTX-sensitive 
currents were perfused with hyperosmolar sucrose in the presence of 5 nM P-CTX-1. These 
hyperpolarising shifts in the V1/2 were not statistically different to the –22 ± 4 mV shift induced by 
P-CTX-1 alone observed previously (Strachan et al., 1999) (Table 3). No significant changes in the 
slope factor (k) were noted in the Trolox® and L-ascorbic acid h∞ curves.  
 
4. Discussion 
The present study shows that P-CTX-1 causes mammalian neuronal cell swelling presumably 
due to secondary effects following Na+ loading. Previous studies have shown several strains of 
ciguatoxin induce swelling of nerves in amphibians (Benoit et al., 1996; Mattei et al., 1997; Mattei et 
al., 1999a; Mattei et al., 1999b). This appears to be the consequence of continuous Na+ influx due to 
persistent activation of Nav channels at the resting membrane potential and during spontaneous or 
evoked repetitive firing of action potentials (Benoit et al., 1986; Benoit et al., 1996; Hogg et al., 1998; 
Strachan et al., 1999). This is accompanied by the influx of water to maintain the osmotic equilibrium 
resulting in nodal swelling. The sodium loading hypothesis described above is supported by the 
finding that the sodium channel blocker TTX prevents this swelling (Benoit et al., 1996; Mattei et al., 
1997; Mattei et al., 1999a; Mattei et al., 1999b). This swelling has been associated with sensory 
disturbances, such as alterations to nerve conduction velocity in humans, by increasing the electrical 
capacitance of the nodal membrane (Allsop et al., 1986; Cameron et al., 1991a; 1991b). This may 
contribute to the sensory disturbances characteristic of ciguatera poisoning. Additional support is 
provided in the present study by the lack of a significant alteration in the reversal potential (Vrev) for 
sodium (Fig. 5). Normally, this would be counterbalanced by a compensatory K+ efflux during 
repetitive action potentials. However, ciguatoxins have been shown to block Kv channels in DRG 
neurons (Birinyi-Strachan et al., 2004) and skeletal muscle (Hidalgo et al., 2002). 
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In comparison to frog myelinated nerve fibres (Mattei et al., 1999a; Mattei et al., 1999b), 
however, the increase in DRG neuronal cell size due to perfusion with P-CTX-1 was small. The 
reason for such a large difference in the magnitude of cell swelling most likely lies in the cell 
preparation used in the present experiments. DRG neurons in physiological solutions are turgid which 
result in the inability of these cells to swell significantly before detrimental changes occur. 
Conversely, nodes of Ranvier appear to have a morphology that allows changes in volume more 
readily, especially in their ability to increase, or even double in size.  
Despite the minor effects of P-CTX-1 on DRG neuronal swelling, the changes in cell size, 
although smaller than in amphibian preparations, still indicate that P-CTX-1 acts to induce a 
measurable swelling in mammalian sensory neurons that may contribute to some of the effects of the 
toxin. The present study also shows for the first time that hyperosmolar D-mannitol does reduce 
swelling following perfusion of DRG sensory neurons with P-CTX-1 and that this may contribute to 
its action as a neuroprotectant in ciguatera poisoning to reduce paraesthesiae and dysaesthesiae. 
Importantly, the present study has also shown that both hyper- and iso-osmolar D-mannitol 
significantly reduce the majority of the effects of P-CTX-1 on Nav channel gating and spike 
electrogenesis in mammalian sensory neurons. Under normal conditions P-CTX-1 induced a 
concentration-dependent reduction in both TTX-sensitive and TTX-resistant peak INa amplitude. 
Perfusion of D-mannitol in hyper- and iso-osmolar conditions failed to fully prevent this action. 
However, it is important to note that hyperosmolar D-mannitol in the absence of toxin acts to decrease 
peak INa amplitude and thus overall there was a significant reduction in the effect of P-CTX-1 (Table 
2). Another interesting finding in this study was the ability of iso-osmolar, but not hyperosmolar 
concentrations of D-mannitol to inhibit the P-CTX-1-induced hyperpolarising shift in the 
voltage-dependence of TTX-sensitive Nav channel activation. Overall, however, these actions clearly 
demonstrate that D-mannitol has a direct action to inhibit increases in neuronal excitability presumably 
independent of any osmotic actions to reduce nerve cell swelling. Therefore the therapeutic actions of 
D-mannitol to reduce sensory neurological disturbances are most likely due to a dual action. Firstly, a 
direct action of D-mannitol to inhibit the rapid modulation of Nav channel gating leading to membrane 
depolarisation and tonic or evoked repetitive action potential firing. Secondly, an osmotic action of 
hyperosmolar D-mannitol to reduce the delayed nodal swelling caused by a continual Na+ influx 
resulting from the aforementioned modulation of Nav channel gating and block of compensatory K+ 
efflux via Kv channels (Hidalgo et al., 2002; Birinyi-Strachan et al., 2004).  
Interestingly, hyperosmolar D-mannitol solutions also partially inhibited the increase in AP 
duration due to the perfusion of P-CTX-1. This increase in AP duration is the result of a 
P-CTX-1-induced block of various Kv channels (Benoit and Legrand, 1994; Birinyi-Strachan et al., 
2004) and not a slowing of Nav channel inactivation (Strachan et al., 1999). These findings therefore 
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suggest that D-mannitol directly affects the association of P-CTX-1 with certain subtypes of Nav and 
possibly Kv, channels present in DRG neurons, in concert with its action to reverse any cell swelling 
induced by Na+ loading. 
Prolonged washout in toxin-free D-mannitol solutions did not reverse the P-CTX-1-induced 
reduction in peak INa the hyperpolarising shift in steady-state inactivation or the increase in the rate of 
recovery from inactivation. The ability of pre, but not post-application of D-mannitol to inhibit the 
effect of P-CTX-1 on INa amplitude, indicates that D-mannitol reduces P-CTX-1 association rates, but 
has little effect on P-CTX-1 dissociation rates in mammalian sensory neurons. Such an action 
supports the findings that mannitol is most effective in treating ciguatera early in the course of the 
disease (Schnorf et al., 2002). 
To determine if the above actions were specific for D-mannitol, further experiments investigated 
the ability of the structurally related acyclic polyol, D-sorbitol, and the unrelated cyclic sugar, sucrose, 
to inhibit these P-CTX-1-induced changes in neuronal excitability. Under voltage- and current-clamp 
conditions, D-sorbitol and sucrose failed to prevent P-CTX-1 induced increases in neuronal 
excitability further emphasising the unique action of D-mannitol to inhibit P-CTX-1-induced 
alterations in spike electrogenesis.  
Previous studies have postulated that ciguatoxins may generate hydroxyl free radicals given the 
highly oxygenated nature of the cyclic polyether structure (Pearn et al., 1989; Benoit et al., 1996). In 
support of this postulate, D-mannitol is a known scavenger of hydroxyl radicals with a rate constant, k, 
of 1.7 x 109 dm3/mol/s (Buxton et al., 1988). Therefore the neuroprotectant action of D-mannitol may 
be due to this action. This is the first study to show that only high concentrations of P-CTX-1 produce 
free radicals and only in the presence of biological tissue. The mechanism for this generation of 
hydroxyl radicals is presently unknown and it cannot be excluded that high concentrations of P-CTX-
1 do not cause cell apoptosis leading to production of free radicals. Importantly, P-CTX-1 at very high 
concentrations (500 nM) did not generate free radicals in the absence of biological tissue. In addition, 
it appears that 5-10 nM P-CTX-1, concentrations that produce profound alterations in spike 
electrogenesis and Nav channel gating, fail to produce measurable amounts of hydroxyl free radicals. 
Thus while P-CTX-1 may generate hydroxyl free radicals, significant levels only occur at doses much 
higher than those that alter neuronal excitability. 
One possible limitation of the EPR experiments could be that generation of free radicals at low 
P-CTX-1 concentrations, sufficient to alter neuronal excitability, are below the limit of detection using 
EPR spectroscopy. To investigate this possibility, patch clamp experiments were carried out to 
determine if known and highly efficacious free radical scavengers could prevent the actions of P-
CTX-1. Accordingly voltage-clamp experiments investigated the ability of Trolox® with a rate 
constant for reaction with hydroxyl radicals, k, of 7 x 109 dm3/mol/s (Davies et al., 1988) and L-
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ascorbic acid with a k value of 1.1 x 1010 dm3/mol/s (Buxton et al., 1988), to inhibit these P-CTX-1-
induced changes in neuronal excitability. Unlike the actions of D-mannitol, both of these free radical 
scavengers failed to inhibit any of the P-CTX-1-induced alterations in Nav channel gating. These 
results again suggest a different mechanism of action of D-mannitol in inhibiting P-CTX-1 effects on 
sodium channels, compared to the other osmotic and radical scavenging agents. Finally, it is salient to 
note that sucrose, which has a rate constant, k, of 2.3 x 109 dm3/mol/s for reaction with hydroxyl 
radicals, is a more efficacious scavenger of free radicals than D-mannitol, with a k value of 1.7 x 109 
dm3/mol/s. Indeed, even D-sorbitol is comparable to D-mannitol with a rate constant of 1.5 x 109 
dm3/mol/s. Therefore since hyperosmolar sucrose failed to prevent any of the alterations in channel 
gating or spike electrogenesis it is highly unlikely that the neuroprotectant effect of D-mannitol in 
mammalian DRG neurons is due solely to a osmotic reduction of neuronal swelling or the scavenging 
of hydroxyl free radicals. In addition, D-mannitol is unlikely to directly detoxify the polyether toxin, 
since spontaneous nerve activity reappears rapidly upon washout of D-mannitol in many preparations 
(Mattei et al., 1999b), albeit not in DRG neurons. These data and previous studies indicate that 
additional actions of mannitol to inhibit toxin association (kon) with the Nav channel may play an 
important role. Future experiments could address this using radioligand binding studies. 
The findings of the present study suggest that the neuroprotectant action of D-mannitol on DRG 
Nav channels involves a direct effect on toxin association to receptor site 5, but not on its displacement 
from the Nav channel. Thus at iso-osmolar concentrations, D-mannitol prevents but does not reverse 
the actions of P-CTX-1. This is in accordance with the inability of D-mannitol to reverse 
ciguatoxin-induced changes in DRG Nav channel gating after sustained washout. Presently, other 
evidence to suggest that prior incubation with iso-osmotic D-mannitol prevents subsequent binding of 
site 5 neurotoxins such as ciguatoxin, or other site 5 neurotoxins, is lacking. This action on Nav 
channels expressed in DRG neurons differs from effects in other preparations where post-application 
of hyperosmolar concentrations of D-mannitol (Benoit et al., 1996; Mattei et al., 1999b), 
hyperosmolar sucrose or TMA (Benoit et al., 1996) reversed the effects of ciguatoxin. However, given 
that hyperosmolar solutions not containing mannitol are also effective indicates that these effects may 
arise through the reduction in nodal swelling, prominent in amphibian preparations. 
Despite clear prevention of the effects of P-CTX-1 on the gating of DRG Nav channels, 
D-mannitol appears to have limited effect on the signs of toxicity or survival of mice (Lewis et al., 
1993). In addition, mannitol fails to prevent the actions of P-CTX-1 on human atrial trabeculae (Lewis 
et al., 1992) but, to varying degrees, it does inhibit actions on motor nerve fibres (Lewis et al., 1993). 
Given that humans experience, in many cases, a rapid relief of the sensory neurological symptoms of 
acute ciguatera, it would appear that the neuroprotectant effects of mannitol treatment appears to be 
mainly confined to Nav channels mediating sensory and, in some cases, motor function and not those 
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associated with autonomic or cardiac function. D-Mannitol also appears not to reverse or prevent toxic 
effects of central origin in mice or cats (Lewis et al., 1993) although this may due to the rapid effects 
in theses species or subtle differences in sodium channel subtypes between species. Thus ciguatoxins 
appear to target one or several of the TTX-sensitive DRG Nav subtypes including Nav1.1, Nav1.6 or 
Nav1.7 that have been shown to be highly expressed in DRG neurons (for a review of Nav subtypes 
see (Catterall, 2000). Given the limited actions of P-CTX-1 on DRG neurons expressing 
TTX-resistant Nav channels, it would appear that the Nav1.8 and Nav1.9 channel subtypes are not 
involved to any appreciable extent. From previous work, ciguatoxins appear to modulate Nav1.7 
expressed in motor nerves (Benoit et al., 1996) and Nav1.4 expressed in skeletal muscle (Hidalgo et 
al., 2002; Bottein Dechraoui and Ramsdell, 2003). However there appear to be conflicting reports of 
actions on the cardiac Nav channels. In isolated cardiac muscle preparations, ciguatoxins only have a 
direct action at high concentrations, with an indirect action mediated via nerve-evoked noradrenaline 
release predominating at lower concentrations (Lewis and Endean, 1986; Seino et al., 1988; Lewis et 
al., 1992; Sauviat et al., 2002). This is borne out clinically with only severe cases presenting with 
cardiac problems. However, this is in contrast to potent actions of P-CTX-3C in radioligand binding 
experiments using HEK293 cells expressing cardiac Nav1.5 (hH1) channels (Bottein Dechraoui and 
Ramsdell, 2003). Presently it is unclear which Nav channels ciguatoxins target in the CNS (Nav1.1, 
1.2, 1.3 or 1.6), but they do target Nav1.2 in rat brain synaptosomes (Bidard et al., 1984; Bottein 
Dechraoui and Ramsdell, 2003), the predominant subtype in this preparation (Gordon et al., 1987). 
In conclusion, the role of mannitol in reversing the symptoms of ciguatera is not limited to an 
osmotic reduction of peripheral nodal swelling, but rather involves a more complex process possibly 
involving an inhibition of toxin association with Nav channels. Future experiments should address this 
issue using radioligand binding techniques. The differences in the effects of ciguatoxins between 
DRG neurons and other mammalian or amphibian preparations may also relate to the unique Nav 
channel subtypes present in these sensory cell bodies in this species. Therefore future studies are 
required to determine which Nav channel subtypes are the target for ciguatoxins.  
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Figure Legends 
Fig. 1. Hydroxyl free radical formation by P-CTX-1. (Aa) Control spectrum recorded in the presence 
of 10 mM DMPO trapping agent. (Ab) No increased generation of hydroxyl free radicals, as 
evidenced by the intensity of the signal from the DMPO-OH adduct, was observed following the 
addition of 500 nM P-CTX-1. (B) The presence of cellular material was required for •OH formation by 
P-CTX-1. (Ba) Control spectra recorded in the presence of 55 mM DMPO and dissociated DRG 
neurons (>500 cells/ml) in DMEM culture medium. (Bb) Typical increase in spectral intensity 
amplitude in the presence of 80 nM P-CTX-1, recorded in the presence of DRG neurons and DMPO. 
(C) Lack of generation of free radicals at concentrations of P-CTX-1 that modulate Nav channel gating 
and spike electrogenesis. (Ca) Control spectra were recorded in the presence of 40 mM DMPO 
trapping agent and DRG neurons. (Cb) No significant generation of radical species occurred in the 
presence of 10 nM P-CTX-1, recorded in the presence of DRG neurons and DMPO.  
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Fig. 2. The effect of D-mannitol on P-CTX-1-modified action potentials (AP) in DRG neurons 
expressing TTX-sensitive Nav channels. (A) Superimposed APs generated by supramaximal current 
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pulses prior to (a), and following (b), perfusion with 10 nM P-CTX-1. Note the membrane 
depolarisation in the presence of P-CTX-1. (B-C) Typical recordings of the effect of hyperosmolar 
(B) and iso-osmolar (C) 50 mM mannitol in the presence (b), or absence (a), of 10 nM P-CTX-1.  
 
Fig. 3. Action of D-mannitol on the P-CTX-1-induced rise in leakage current (Ileak) through 
TTX-sensitive Nav channels. Absolute changes in Ileak (–nA) were recorded in either (¢) 
hyperosmolar (n = 13) or (p) iso-osmolar (n = 9) 50 mM D-mannitol solutions. Data were initially 
recorded during a 10 min perfusion in D-mannitol alone (¡). Cells were then perfused for a further 10 
mins with 5 nM P-CTX-1 in the presence of either hyper- or iso-osmolar 50 mM D-mannitol. The 
mean rise in Ileak after perfusion with 5 nM P-CTX-1 alone (!) is shown for comparison. 
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Fig. 4. Actions of D-mannitol on the P-CTX-1-induced inhibition of peak INa. Depolarising test pulses, 
from a holding potential of –80 mV to –10 mV for 50 ms every 10 s, were employed to generate 
TTX-sensitive (A,C) and TTX-resistant (B,D) INa. Panels show the effects of hyperosmolar (A-B) or 
iso-osmolar (C-D) 50 mM D-mannitol. Each panel shows superimposed INa recorded under control 
conditions (trace a), 10 min after perfusion with D-mannitol (trace b), and a further 10 min following 
perfusion with 5 nM P-CTX-1 plus 50 mM D-mannitol (trace c). Insets in panels A and C show 
magnified peak TTX-sensitive INa. 
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Fig. 5. Actions of D-mannitol on P-CTX-1-induced alterations in the voltage dependence of 
TTX-sensitive Nav activation. (A-D) Families of TTX-sensitive INa were elicited (see inset) before (A, 
C), and following, a 10 min perfusion with 5 nM P-CTX-1 plus hyperosmolar (B), or iso-osmolar (D), 
50 mM D-mannitol. (E-F) Peak current/voltage (INa/V) relationships are graphed in the absence (¡) 
and presence (●) of 5 nM P-CTX-1 plus hyperosmolar (E) or iso-osmolar (F) 50 mM D-mannitol. For 
clarity, only INa recorded in 10 mV steps are presented. Data were normalised to peak inward INa and 
then fitted with Equation 1, n ≥ 4 experiments.  
 
 L.C. Birinyi-Strachan et al.  30 
Fig. 6. Effects of D-mannitol on P-CTX-1-induced alterations in steady-state TTX-sensitive Nav 
channel inactivation (h∞). Steady-state inactivation was determined using a two-pulse protocol (see 
inset in A). (A) Typical TTX-sensitive INa traces obtained following a 40-ms test pulse (Vtest) to –10 
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mV subsequent to prepulses of –130, –80 and –40 mV. Current traces were recorded before (left hand 
traces), and following a 10 min perfusion with 5 nM P-CTX-1 in the presence of hyperosmolar 50 
mM D-mannitol (right hand traces). (B-E) Peak INa recorded during the test pulse were expressed as a 
fraction of maximum control INa (B, D) or normalised to peak INa amplitude (C, E), and plotted against 
prepulse potential. The amount of INa that is available for activation under control conditions (¡), and 
during perfusion with 5 nM P-CTX-1 plus 50 mM D-mannitol (l), is shown under hyperosmolar 
(C-D, n ≥ 9) and iso-osmolar (E-F, n ≥ 7) conditions. The h∞/V curves were fitted to equation 2. 
 
Fig. 7. Effects of D-mannitol on the P-CTX-1-induced increase in TTX-resistant Nav channel 
repriming kinetics. The rate of recovery from inactivation was assessed using a standard two-pulse 
protocol (see inset), where ΔT represents a variable interpulse interval. Nav channel repriming rate 
was determined by normalising peak INa elicited during the test pulse (Vtest) against peak currents 
recorded during the conditioning pulse (Vcond) and plotted as a function of the interpulse interval. 
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(A-D) TTX-Resistant INa were recorded under control conditions (¡), and following a 10 min 
perfusion with 5 nM P-CTX-1 (l) in the presence of hyperosmolar (A-B), or iso-osmolar (C-D), 50 
mM D-mannitol. (B, D) The magnitude of the unrecovered fraction of current was plotted on a 
semilogarithmic scale. Data were fitted to the sum of two exponential functions according to equation 
3, n ≥ 4 for all experiments. 
